Review of in vivo pharmacokinetics and toxicology of phosphorothioate oligonucleotides

Van Der Krol AR, 1988, Modulation of eukaryotic gene expression by complementary RNA or DNA sequences, Bio Techniques, 6, 958

10.1021/cr00102a001

Cazenave C, 1991, Antisense Nucleic Acids and Proteins. Fundamentals and Applications, 47

10.1016/0168-9525(85)90010-1

10.1146/annurev.bi.55.070186.003033

10.1073/pnas.83.12.4143

Goodchild J, 1989, Antisense Inhibitors of Gene Expression, 54

10.1016/S0040-4039(01)89794-X

Rayner B, 1989, Antisense Inhibitors of Gene Expression, 119

Stein CA, 1989, Antisense Inhibitors of Gene Expression, 97

10.1023/A:1015985728434

10.1093/nar/15.14.5749

Miller PS, 1987, A new approach to chemotherapy based on molecular biology and nucleic acid chemistry: Mutagen (masking tape for gene expression), Anticancer Drug Design, 2, 117

Paoletti C, 1988, Anti‐sense oligonucleotides as potential antitumor agents: Prospective views and preliminary results, Anticancer Drug Design, 2, 325

10.1021/bc00003a001

Cohen JS, 1990, Design of Anti‐AIDS Drugs, 195

Tidd D, 1990, A potential role for antisense oligonucleotide analogues in the development of oncogene targeted cancer chemotherapy, Anticancer Res, 10, 1169

10.1016/0006-2952(90)90300-A

10.1016/0167-4781(90)90031-V

Knorre D, 1990, Antisense oligonucleotide derivatives as genetargeted drugs, Biomed Sci (USSR), 1, 334

Calabretta B, 1991, Inhibition of protooncogene expression by antisense oligodeoxynucleotides: biological and therapeutic implications, Cancer Res, 51, 4505

Miller PS, 1989, Antisense Inhibitors of Gene Expression, 79

10.1073/pnas.86.10.3474

10.1093/nar/19.20.5743

Chused TM, 1972, The clearance and localization of nucleic acids by New Zealand and normal mice, Clin Exp Immunol, 12, 465

Dorsch CA, 1975, Persistence of DNA in the circulation of immunized rabbits, Rheumatology, 212, 161

10.1084/jem.147.3.684

Emlen W, 1982, Effect of preformed immune complexes on the clearance and tissue localization of single stranded DNA in mice, Clin Exp Immunol, 40, 264

Emlen W, 1984, Effect of DNA size and strandedness on the in vivo clearance and organ localization of DNA, Clin Exp Immunol, 56, 185

10.1073/pnas.85.15.5507

10.1089/ard.1991.1.153

10.1093/nar/19.17.4695

Griffin LC, 1993, In vivo anti‐coagulant properties of a novel nucleotide‐based thrombin inhibitor and demonstration of regional anticoagulation in extracorporeal circuits, Blood, 81, 3271, 10.1182/blood.V81.12.3271.3271

10.1093/nar/20.2.307

Karamyshev VN, 1993, Distribution and stability of oligonucleotide derivatives in mouse tissues, Biokhimiya, 58, 590

Colvin OM, 1990, Disposition and metabolism of oligodeoxynucleoside methylphosphonate following a single iv injection in mice (short communication), Drug Metab Dispos, 18, 815

10.1016/S0378-4347(00)82193-3

10.1073/pnas.88.17.7595

Temsamani J, 1992, Capped oligodeoxynucleotide phosphorothioates: Pharmacokinetics and stability in mice, 318

10.1002/bdd.2510130308

Cossum PA, 1993, Disposition of the 14C‐labeled phosphorothioate oligonucleotide ISIS 2105 after intravenous administration to rats, J Pharmacol Exp Ther, 267, 1181

Cornish KG, 1993, Cardiovascular effects of a phosphorothioate oligonucleotide with sequence antisense to p53 in the conscious rhesus monkey, Pharmacol Commun, 3, 239

10.1089/ard.1994.4.43